{"id":300348,"date":"2025-07-10T19:47:41","date_gmt":"2025-07-10T19:47:41","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/gpc-stock\/"},"modified":"2025-07-10T19:47:41","modified_gmt":"2025-07-10T19:47:41","slug":"gpc-stock","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/knowledge-base\/markets\/gpc-stock\/","title":{"rendered":"GPC Stock: Comprehensive Analysis and Investment Opportunities 2025"},"content":{"rendered":"
<\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":45,"featured_media":178545,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[21],"tags":[47,39,45],"class_list":["post-300348","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-markets","tag-beginner","tag-platform","tag-stock"],"acf":{"h1":"Pocket Option analyzes GPC stock","h1_source":{"label":"H1","type":"text","formatted_value":"Pocket Option analyzes GPC stock"},"description":"Explore detailed insights on GPC stock - technical analysis, growth prospects and effective investment strategies from Pocket Option experts. Essential information for Vietnamese investors today!","description_source":{"label":"Description","type":"textarea","formatted_value":"Explore detailed insights on GPC stock - technical analysis, growth prospects and effective investment strategies from Pocket Option experts. Essential information for Vietnamese investors today!"},"intro":"This article provides an in-depth perspective on GPC stock of Imexpharm Pharmaceutical Joint Stock Company, one of the notable securities on the Vietnamese market. Through technical analysis, fundamental assessment, and consideration of macroeconomic factors, the article helps investors make smart decisions in the context of the 2025 market.","intro_source":{"label":"Intro","type":"text","formatted_value":"This article provides an in-depth perspective on GPC stock of Imexpharm Pharmaceutical Joint Stock Company, one of the notable securities on the Vietnamese market. Through technical analysis, fundamental assessment, and consideration of macroeconomic factors, the article helps investors make smart decisions in the context of the 2025 market."},"body_html":"

Overview of GPC Stock and Its Position in Vietnam's Pharmaceutical Industry<\/h2><\/div>

GPC stock belongs to Imexpharm Pharmaceutical Joint Stock Company, one of Vietnam's leading pharmaceutical enterprises established in 1977. With over 40 years of development, Imexpharm has built a solid position in the domestic and regional pharmaceutical markets. The company specializes in manufacturing and trading high-quality pharmaceutical products, particularly antibiotics and functional foods.<\/p><\/div>

In the context of Vietnam's rapidly developing pharmaceutical industry, GPC stock is increasingly attracting investor attention. The Vietnamese pharmaceutical market is forecast to achieve a compound annual growth rate (CAGR) of approximately 10-12% during the 2023-2028 period, higher than the global average. This is an important driving force for the development prospects of domestic pharmaceutical companies, including Imexpharm.<\/p><\/div>

Regarding competitive position, Imexpharm stands out with its sustainable development strategy, focusing on high-quality product lines that meet EU-GMP and WHO-GMP standards. This is an important competitive advantage, especially as Vietnamese consumers increasingly care about drug quality and the trend of using domestically produced medicines rises. In 2024, Imexpharm launched a high-tech antibiotic manufacturing plant, contributing to enhanced production capacity and expanded product portfolio.<\/p><\/div>

Indicator<\/th>2022<\/th>2023<\/th>2024<\/th>2025 Forecast<\/th><\/tr><\/thead>
Revenue (billion VND)<\/td>1,480<\/td>1,650<\/td>1,842<\/td>2,100<\/td><\/tr>
Net Profit (billion VND)<\/td>248<\/td>290<\/td>325<\/td>380<\/td><\/tr>
EPS (VND)<\/td>3,750<\/td>4,200<\/td>4,650<\/td>5,400<\/td><\/tr>
ROE (%)<\/td>14.2<\/td>15.3<\/td>16.1<\/td>17.2<\/td><\/tr><\/tbody><\/table><\/div><\/div>

Fundamental and Financial Analysis of GPC Stock<\/h2><\/div>

Fundamental analysis is an important step when evaluating the potential of GPC stock. Imexpharm's business results in recent years show stable growth. In 2024, the company achieved revenue of 1,842 billion VND, an increase of 11.6% compared to 2023. Net profit reached 325 billion VND, up 12.1% compared to the previous year. This is impressive growth in a market that still faces many challenges.<\/p><\/div>

Imexpharm's financial indicators are also quite positive. The gross profit margin is maintained at 38-40%, higher than the industry average. ROE (Return on Equity) reached 16.1% in 2024, up from 15.3% in 2023. The current P\/E ratio is around 12-13 times, lower than the pharmaceutical industry average of about 15-16 times, indicating the stock's price appreciation potential.<\/p><\/div>

Valuation Metrics Analysis<\/h3><\/div>
Indicator<\/th>GPC<\/th>Industry Average<\/th>Assessment<\/th><\/tr><\/thead>
P\/E<\/td>12.5<\/td>15.8<\/td>Attractive<\/td><\/tr>
P\/B<\/td>1.98<\/td>2.25<\/td>Reasonable<\/td><\/tr>
EV\/EBITDA<\/td>8.2<\/td>9.5<\/td>Attractive<\/td><\/tr>
Dividend Yield (%)<\/td>3.5<\/td>2.8<\/td>Good<\/td><\/tr><\/tbody><\/table><\/div><\/div>

Regarding financial condition, Imexpharm has a healthy capital structure with a low debt-to-equity ratio (about 0.3 times). The company has abundant cash, accounting for about 15% of total assets, allowing the business to have sufficient resources to fund expansion projects and research and development of new products. Particularly, in the current context of decreasing interest rates, Imexpharm's low debt is a significant advantage.<\/p><\/div>

Another noteworthy point is the company's dividend policy. Imexpharm maintains regular dividend payments of about 15-20% in cash and shares, demonstrating its commitment to sharing profits with shareholders. At the current price, the dividend yield of GPC stock is around 3.5%, higher than bank deposit interest rates and the industry average.<\/p><\/div>

Technical Analysis and Trading Trends of GPC Stock<\/h2><\/div>

Technical analysis provides valuable insight into price trends and ideal entry\/exit points for investors. According to technical charts, GPC stock went through an accumulation phase during the first six months of 2024 and began an uptrend from Q3\/2024. Currently, the stock is trading above the MA50 (50-day moving average) and MA200 (200-day moving average), confirming medium and long-term upward trends.<\/p><\/div>

Technical indicators such as RSI (Relative Strength Index) are at 65, showing that the stock is not yet in the overbought zone. MACD is also above the signal line with positive momentum. The average trading volume in the last 20 sessions increased by 30% compared to the previous 20 sessions, reflecting increasing investor interest.<\/p><\/div>

Technical Indicator<\/th>Current Value<\/th>Signal<\/th><\/tr><\/thead>
RSI (14)<\/td>65<\/td>Positive<\/td><\/tr>
MACD (12,26,9)<\/td>+2.15<\/td>Buy<\/td><\/tr>
Bollinger Bands<\/td>Trading near upper band<\/td>Positive<\/td><\/tr>
Stochastic<\/td>82<\/td>Near overbought zone<\/td><\/tr><\/tbody><\/table><\/div><\/div>

Regarding resistance and support levels, GPC stock currently has strong resistance at the price level of 65,000 VND, corresponding to the highest peak in trading history. Important support levels are at 58,000 VND (MA50) and 52,000 VND (MA200). An appropriate trading strategy is to accumulate purchases at these support levels and consider taking partial profits when approaching resistance zones.<\/p><\/div>

According to analysts at Pocket Option, with the current momentum, GPC stock is likely to break through the 65,000 VND resistance level in Q2\/2025, especially if Q1\/2025 business results continue to be positive. However, investors need to pay attention to risk factors such as general market fluctuations and macroeconomic conditions that could affect price trends.<\/p><\/div>

Notable Technical Patterns<\/h3><\/div>

Recently, GPC stock has formed a \"\"Cup and Handle\"\" pattern - a technical pattern signaling strong price breakout potential. The \"\"cup\"\" was formed during the first 4 months of 2024, followed by a \"\"handle\"\" phase lasting about 6-8 weeks. According to technical analysis theory, the price target after completing this pattern could be 15-20% higher than the current price level.<\/p><\/div>